Electro-mediated drug administration of mitomycin C in preventing non-muscle-invasive bladder cancer recurrence and progression after transurethral resection of the bladder tumour in intermediate- and high-risk patients

Risk Patients ◽

Muscle Invasive ◽

Bladder Cancer Recurrence

MP63-04 QUANTITATIVE NUCLEAR FEATURES OF HEMATOXYLIN-EOSIN SPECIMENS FROM INITIAL TRANSURETHRAL RESECTION FOR PREDICTING NON-MUSCLE INVASIVE BLADDER CANCER RECURRENCE

The Journal of Urology ◽

10.1097/01.ju.0000556847.87489.0a ◽

2019 ◽

Vol 201 (Supplement 4) ◽

Author(s):

Naoto Tokuyama* ◽

Akira Saito ◽

Yosuke Hirasawa ◽

Takeshi Hashimoto ◽

Naoya Satake ◽

...

Keyword(s):

Bladder Cancer ◽

Transurethral Resection ◽

Cancer Recurrence ◽

Invasive Bladder Cancer ◽

Muscle Invasive ◽

Bladder Cancer Recurrence ◽

Hematoxylin Eosin ◽

Nuclear Features

Re: Prospective Randomized Trial of Hexylaminolevulinate Photodynamic-Assisted Transurethral Resection of Bladder Tumour (TURBT) plus Single-Shot Intravesical Mitomycin C vs Conventional White-Light TURBT plus Mitomycin C in Newly Presenting Non-Muscle-Invasive Bladder Cancer

The Journal of Urology ◽

10.1016/j.juro.2014.05.099 ◽

2014 ◽

Vol 192 (3) ◽

pp. 723-723

Author(s):

David P. Wood

Keyword(s):

Bladder Cancer ◽

Randomized Trial ◽

Mitomycin C ◽

White Light ◽

Transurethral Resection ◽

Bladder Tumour ◽

Prospective Randomized Trial ◽

Single Shot ◽

The value of perioperative mitomycin C instillation in improving subsequent bacillus calmette-guerin instillation efficacy in intermediate and high-risk patients with non-muscle invasıve bladder cancer: a prospective randomized study

International braz j urol ◽

10.1590/s1677-55382012000400006 ◽

2012 ◽

Vol 38 (4) ◽

pp. 474-479 ◽

Cited By ~ 10

Author(s):

Ömer Gülpinar ◽

Ahmet H. Halilioğlu ◽

Mehmet İlker Gökçe ◽

Çagatay Göğüş ◽

Sümer Baltaci

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Mitomycin C ◽

Randomized Study ◽

Invasive Bladder Cancer ◽

Prospective Randomized Study ◽

Risk Patients ◽

Sequential Combination of Mitomycin C Plus Bacillus Calmette-Guérin (BCG) Is More Effective but More Toxic Than BCG Alone in Patients with Non–Muscle-invasive Bladder Cancer in Intermediate- and High-risk Patients: Final Outcome of CUETO 93009, a Randomized Prospective Trial

European Urology ◽

10.1016/j.eururo.2014.09.026 ◽

2015 ◽

Vol 67 (3) ◽

pp. 508-516 ◽

Cited By ~ 30

Author(s):

Eduardo Solsona ◽

Rosario Madero ◽

Venancio Chantada ◽

Jesus M. Fernandez ◽

Juan A. Zabala ◽

...

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Mitomycin C ◽

Prospective Trial ◽

Risk Patients ◽

Randomized Prospective Trial ◽

Sequential Combination ◽

Significance of the interval between first and second transurethral resection on recurrence and progression rates in patients with high-risk non-muscle-invasive bladder cancer treated with maintenance intravesical Bacillus Calmette-Guérin

BJU International ◽

10.1111/bju.13102 ◽

2015 ◽

Vol 116 (5) ◽

pp. 721-726 ◽

Cited By ~ 17

Author(s):

Sümer Baltacı ◽

Murat Bozlu ◽

Asıf Yıldırım ◽

Mehmet İlker Gökçe ◽

İlker Tinay ◽

...

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Transurethral Resection ◽

Invasive Bladder Cancer ◽

Continuous saline bladder irrigation for two hours following transurethral resection of bladder tumors in patients with non-muscle invasive bladder cancer does not prevent recurrence or progression compared with intravesical Mitomycin-C

BMC Urology ◽

10.1186/s12894-018-0408-6 ◽

2018 ◽

Vol 18 (1) ◽

Cited By ~ 2

Author(s):

Andrew T. Lenis ◽

Kian Asanad ◽

Maher Blaibel ◽

Nicholas M. Donin ◽

Karim Chamie

Keyword(s):

Bladder Cancer ◽

Mitomycin C ◽

Transurethral Resection ◽

Invasive Bladder Cancer ◽

Bladder Tumors ◽

Bladder Irrigation ◽

Re: Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C versus bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-Risk Non-Muscle-Invasive Bladder Cancer

The Journal of Urology ◽

10.1016/j.juro.2018.06.043 ◽

2018 ◽

Vol 200 (4) ◽

pp. 696-697

Author(s):

Sam S. Chang

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Randomised Controlled Trial ◽

Mitomycin C ◽

Adjuvant Treatment ◽

Controlled Trial ◽

Muscle Invasive ◽

Randomised Controlled

Prospective randomized clinical trial of chemohyperthermia with mitomycin-C prior to transurethral resection of the bladder and its relationship with the rate of early recurrence in non-muscle invasive bladder cancer: Intermediate analysis

European Urology Open Science ◽

10.1016/s2666-1683(20)33373-5 ◽

2020 ◽

Vol 19 ◽

pp. e1175-e1176

Author(s):

C. Garcia Alvarez ◽

A.C. Plata Bello ◽

J. Plata Bello ◽

M.A. Tamayo Jover ◽

T. Concepción Masip

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

Randomized Clinical Trial ◽

Mitomycin C ◽

Transurethral Resection ◽

Early Recurrence ◽

Invasive Bladder Cancer ◽

Prospective Randomized Clinical Trial ◽

Cystectomy outcomes in patients who have failed Radiofrequency-induced Thermo-chemotherapeutic Effect Mitomycin-C (RITE-MMC) treatment for high-risk non-muscle invasive bladder cancer (HRNMIBC)–Does it complicate surgery and adversely impact oncological outcome?

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2020.09.016 ◽

2020 ◽

Author(s):

Denosshan Sri ◽

Hack Jae Lee ◽

Sarah El-Gemmal ◽

Chris Backhouse ◽

Andrea Tay ◽

...

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Mitomycin C ◽

Oncological Outcome ◽

Invasive Bladder Cancer ◽

Chemotherapeutic Effect ◽

Lifestyle and Non-muscle Invasive Bladder Cancer Recurrence, Progression, and Mortality: Available Research and Future Directions

Bladder Cancer ◽

10.3233/blc-190249 ◽

2020 ◽

Vol 6 (1) ◽

pp. 9-23

Author(s):

Kyle B. Zuniga ◽

Rebecca E. Graff ◽

David B. Feiger ◽

Maxwell V. Meng ◽

Sima P. Porten ◽

...

Keyword(s):

Bladder Cancer ◽

Cancer Recurrence ◽

Invasive Bladder Cancer ◽

Future Directions ◽

Muscle Invasive ◽

Bladder Cancer Recurrence